You just read:

Blueprint Medicines to Present Initial Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 61st ASH Annual Meeting and Exposition

News provided by

Blueprint Medicines

Nov 06, 2019, 09:00 ET